ENTRADA THERAPEUTICS, INC.

EDGAR

Annual consolidated revenue for 2025: about USD 25.42M, using the latest filing vintage with reviewed corrections applied. Corrected values apply reviewed corrections and remain separate from issuer reports. The previous period, 2024, was about USD 210.8M.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

Window: transactions dated on or after 2025-11-19.

Open-market purchases (code P)
5 transactions, 33,867 shares
Sum of shares × price per share: 291,162.1216
Open-market sales (code S)
42 transactions, 1,534,700 shares
Sum of shares × price per share: 11,583,872.0046

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

  • 2026-09-09 MPM BioVentures 2014, L.P. S 28,837 7.13
  • 2026-09-09 MPM BIOVENTURES 2018, L.P. S 28,837 7.13
  • 2026-09-08 MPM BioVentures 2014, L.P. S 192,500 7.41
  • 2026-09-08 MPM BIOVENTURES 2018, L.P. S 192,500 7.41
  • 2026-09-04 MPM BioVentures 2014, L.P. S 38,500 7.11

5% holders (Schedule 13D and 13G)

  • MPM BioVentures 2014, L.P. 4.5% SCHEDULE 13D/A 09/08/2026
  • MPM BioVentures 2014 (B), L.P. 0.3% SCHEDULE 13D/A 09/08/2026
  • MPM Asset Management Investors BV2014 LLC 0.2% SCHEDULE 13D/A 09/08/2026

See all insider transactions

Latest quarter

Revenue

905 thousand USD

2026 Q3 · USD

Exact inputs and evidence

Operating margin

-4,606.52%

2026 Q3 · %

Exact inputs and evidence
  • Operating Income: -41689000 USD Source
  • Revenue: 905000 USD Source

Operating cash flow

-30 million USD

2026 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: -104122000 USD Source
  • Operating Cash Flow: -74158000 USD Source

Free cash flow

-30.1 million USD

2026 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: -104122000 USD Source
  • Operating Cash Flow: -74158000 USD Source
  • Capital Expenditure: 216000 USD Source
  • Capital Expenditure: 55000 USD Source
Cash and cash equivalents
112 million USD Source
Exact value

112238000 USD

Long-term debt including current maturities
Not available
Shares outstanding
39.2 million shares Source
Exact value

39150334 shares

Reported share-count change

2.44% · 931 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 38219232 shares · 2025-09-30· Source
  • 39150334 shares · 2026-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

3.98 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Revenue: 25421000 USD · 2025-01-01 – 2025-12-31 Source
  • Revenue: 24122000 USD · 2025-01-01 – 2025-09-30 Source
  • Revenue: 875000 USD · 2026-01-01 – 2026-03-31 Source
  • Revenue: 898000 USD · 2026-04-01 – 2026-06-30 Source
  • Revenue: 905000 USD · 2026-07-01 – 2026-09-30 Source

Net income

-161 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Net income: -143750000 USD · 2025-01-01 – 2025-12-31 Source
  • Net income: -104586000 USD · 2025-01-01 – 2025-09-30 Source
  • Net income: -39717000 USD · 2026-01-01 – 2026-03-31 Source
  • Net income: -42763000 USD · 2026-04-01 – 2026-06-30 Source
  • Net income: -39742000 USD · 2026-07-01 – 2026-09-30 Source

Operating cash flow

-136 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Operating cash flow: -128512000 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: -96309000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -41695000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -74158000 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: -41695000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -104122000 USD · 2026-01-01 – 2026-09-30 Source
  • Operating cash flow: -74158000 USD · 2026-01-01 – 2026-06-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.

Latest filing recorded: 2026-11-05.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • Revenue: 3 of 11 periods available· newest 2025-12-31
  • Operating income: 6 of 11 periods available· newest 2025-12-31
  • Net income: 6 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 6 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 6 of 11 periods available· newest 2025-12-31
  • Total assets: 3 of 11 periods available· newest 2025-12-31
  • Total liabilities: 3 of 11 periods available· newest 2025-12-31
  • Current assets: 3 of 11 periods available· newest 2025-12-31
  • Current liabilities: 3 of 11 periods available· newest 2025-12-31
  • Cash and cash equivalents: 3 of 11 periods available· newest 2025-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 3 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    -87.9%

    Prior period

    USD 210.78 million

    –

    Current period

    USD 25.42 million

    –

    Exact inputs and evidence

    25421000 − 210782000 = -185361000 USD

    210782000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    25421000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    -319%

    Prior period

    USD 65.63 million

    –

    Current period

    −USD 143.75 million

    –

    Exact inputs and evidence

    -143750000 − 65626000 = -209376000 USD

    65626000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -143750000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    −USD 86.96 million

    Prior period

    −USD 41.56 million

    –

    Current period

    −USD 128.51 million

    –

    Exact inputs and evidence

    -128512000 − -41557000 = -86955000 USD

    -41557000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -128512000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    -67%

    Prior period

    USD 3.16 million

    –

    Current period

    USD 1.04 million

    –

    Exact inputs and evidence

    1041000 − 3158000 = -2117000 USD

    3158000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    1041000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

  • Revenue USD 25.42 million 100% of revenue
  • Operating costs Derived USD 183.32 million 721% of revenue
  • Operating income −USD 157.9 million −621% of revenue
  • Tax, interest and other Derived −USD 14.15 million −56% of revenue
  • Net income −USD 143.75 million −565% of revenue

Cash

  • Operating cash flow −USD 128.51 million −506% of revenue
  • Capital expenditure USD 1.04 million 4.1% of revenue
  • Free cash flow Derived −USD 129.55 million −510% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2023 Operating loss: operating costs were 102% of revenue.
  • 2024 Net income was higher than operating income, so the split is not drawn.
  • 2025 Operating loss: operating costs were 721% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2023 2023-01-01 – 2023-12-31129013000 132175000 Derived -3162000 3523000 Derived -6685000 134189000 Derived
Source
2024 2024-01-01 – 2024-12-31210782000 163771000 Derived 47011000 -18615000 Derived 65626000 -44715000 Derived
Source
2025 2025-01-01 – 2025-12-3125421000 183319000 Derived -157898000 -14148000 Derived -143750000 -129553000 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 25.4M 2025
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.227.6M170.7M113.8M56.9M0.0202320242025
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2023Revenue129013000
2024Revenue210782000
2025Revenue25421000

Revenue growth

Change in revenue from the same financial period one year earlier.

-87.9% 2025
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.75%32%-12%-56%-100%202320242025
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2023Year over yearNo prior comparable period
2024Year over year63.4%
2025Year over year-87.9%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -621.1% 2025
Net margin -565.5% 2025
Free cash flow margin -509.6% 2025
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.162%-48%-259%-469%-679%202320242025
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2023Operating margin-2.5%
2024Operating margin22.3%
2025Operating margin-621.1%
2023Net margin-5.2%
2024Net margin31.1%
2025Net margin-565.5%
2023Free cash flow margin104%
2024Free cash flow margin-21.2%
2025Free cash flow margin-509.6%

Operating cash flow

Cash generated by the company’s normal business operations.

USD -128.5M 2025
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.161.3M83.5M5.6M-72.2M-150.0M202320242025
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2023Operating cash flow139803000
2024Operating cash flow-41557000
2025Operating cash flow-128512000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -129.6M 2025
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.155.3M78.8M2.3M-74.2M-150.7M202320242025
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2023Free cash flow134189000
2024Free cash flow-44715000
2025Free cash flow-129553000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

18.9% 2025
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.52%39%26%13%0%202320242025
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2023Liabilities / assets48.3%
2024Liabilities / assets18.6%
2025Liabilities / assets18.9%

Current assets to current liabilities

Current assets divided by current liabilities.

12.53× 2025
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.13.53×10.15×6.76×3.38×0.00×202320242025
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2023Current assets / current liabilities2.33×
2024Current assets / current liabilities11.15×
2025Current assets / current liabilities12.53×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2020 2020-01-01 – 2020-12-31
−USD 26.52 million
Exact value

Exact value: -26523000 USD

2020-01-01 – 2020-12-31: -26523000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 25.57 million
Exact value

Exact value: -25570000 USD

2020-01-01 – 2020-12-31: -25570000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 2.32 million
Exact value

Exact value: 2318000 USD

2020-01-01 – 2020-12-31: 2318000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 27.89 million
Calculation and evidence

-25570000 − 2318000 USD

Exact free cash flow: -27888000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2021 2021-01-01 – 2021-12-31
−USD 51.16 million
Exact value

Exact value: -51158000 USD

2021-01-01 – 2021-12-31: -51158000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 50.86 million
Exact value

Exact value: -50862000 USD

2021-01-01 – 2021-12-31: -50862000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 4.58 million
Exact value

Exact value: 4580000 USD

2021-01-01 – 2021-12-31: 4580000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 55.44 million
Calculation and evidence

-50862000 − 4580000 USD

Exact free cash flow: -55442000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−USD 94.6 million
Exact value

Exact value: -94600000 USD

2022-01-01 – 2022-12-31: -94600000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 93.79 million
Exact value

Exact value: -93786000 USD

2022-01-01 – 2022-12-31: -93786000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 2.89 million
Exact value

Exact value: 2887000 USD

2022-01-01 – 2022-12-31: 2887000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 96.67 million
Calculation and evidence

-93786000 − 2887000 USD

Exact free cash flow: -96673000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2023 2023-01-01 – 2023-12-31
−USD 6.69 million
Exact value

Exact value: -6685000 USD

2023-01-01 – 2023-12-31: -6685000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 139.8 million
Exact value

Exact value: 139803000 USD

2023-01-01 – 2023-12-31: 139803000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 5.61 million
Exact value

Exact value: 5614000 USD

2023-01-01 – 2023-12-31: 5614000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 134.19 million
Calculation and evidence

139803000 − 5614000 USD

Exact free cash flow: 134189000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2024-01-01 – 2024-12-31
USD 65.63 million
Exact value

Exact value: 65626000 USD

2024-01-01 – 2024-12-31: 65626000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 41.56 million
Exact value

Exact value: -41557000 USD

2024-01-01 – 2024-12-31: -41557000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 3.16 million
Exact value

Exact value: 3158000 USD

2024-01-01 – 2024-12-31: 3158000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 44.72 million
Calculation and evidence

-41557000 − 3158000 USD

Exact free cash flow: -44715000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2025-01-01 – 2025-12-31
−USD 143.75 million
Exact value

Exact value: -143750000 USD

2025-01-01 – 2025-12-31: -143750000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 128.51 million
Exact value

Exact value: -128512000 USD

2025-01-01 – 2025-12-31: -128512000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.04 million
Exact value

Exact value: 1041000 USD

2025-01-01 – 2025-12-31: 1041000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 129.55 million
Calculation and evidence

-128512000 − 1041000 USD

Exact free cash flow: -129553000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

38 filings · 1,499 latest values · 1,499 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001689375, 1689375, TRDA, edgar:1689375

Also known as CycloPorters, Inc., ENTRADA THERAPEUTICS, INC., Entrada Therapeutics, Inc.